Senior Executive Service Performance Review Board, 74493 [2023-23993]
Download as PDF
Federal Register / Vol. 88, No. 209 / Tuesday, October 31, 2023 / Notices
information collection burdens that
apply to IP CTS due to the Accessible
Carceral Communications Order.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Federal Communications Commission.
Katura Jackson,
Federal Register Liaison.
[Docket No. CDC–2023–0027, NIOSH–350]
[FR Doc. 2023–23935 Filed 10–30–23; 8:45 am]
World Trade Center Health Program;
Youth Research Cohort; Request for
Information
BILLING CODE 6712–01–P
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Request for information;
reopening of comment period.
AGENCY:
FEDERAL TRADE COMMISSION
Senior Executive Service Performance
Review Board
AGENCY:
ACTION:
Notice.
Notice is hereby given of the
appointment of members to the FTC
Performance Review Board.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Diane Campbell, Chief Human Capital
Officer, 600 Pennsylvania Avenue NW,
Washington, DC 20580, (202) 436–0152.
SUPPLEMENTARY INFORMATION:
Publication of the Performance Review
Board (PRB) membership is required by
5 U.S.C. 4314 (c) (4). The PRB reviews
and evaluates the initial appraisal of a
senior executive’s performance by the
supervisor, and makes
recommendations regarding
performance ratings, performance
awards, and pay-for-performance pay
adjustments to the Chair.
The following individuals have been
designated to serve on the Commission’s
Performance Review Board:
lotter on DSK11XQN23PROD with NOTICES1
Dianne Campbell, Chief Human Capital
Officer
Anisha Dasgupta, General Counsel
Monique Fortenberry, Director, Office of
Workplace Inclusivity & Opportunity
Tara Koslov, Deputy Director, Bureau of
Competition
Alison Oldale, Deputy Director, Bureau
of Economics
David Robbins, Executive Director, PRB
Chair
Monica Vaca, Deputy Director, Bureau
of Consumer Protection
By direction of the Commission.
April J. Tabor,
Secretary.
[FR Doc. 2023–23993 Filed 10–30–23; 8:45 am]
BILLING CODE 6750–01–P
VerDate Sep<11>2014
17:18 Oct 30, 2023
Jkt 262001
CDC’s National Institute for
Occupational Safety and Health
(NIOSH) is extending the public
comment period for a request for
information (RFI) that was initially
published April 26, 2023 and extended
on August 18, 2023, regarding a World
Trade Center (WTC) Health Program
research cohort for future studies on
health, social, and educational impacts
among persons exposed to the
September 11, 2001, terrorist attacks
who were aged 21 years or younger at
the time of their exposures. With this
notice, the comment period is extended
an additional 90 days to allow
interested parties additional time to
respond.
DATES: Comments must be received by
January 29, 2024.
ADDRESSES: Comments may be
submitted through either of the
following two methods:
• Federal eRulemaking Portal: https://
www.regulations.gov (follow the
instructions for submitting comments),
or
• By Mail: NIOSH Docket Office,
Robert A. Taft Laboratories, MS C–34,
1090 Tusculum Avenue, Cincinnati,
Ohio 45226–1998.
Instructions: All written submissions
received in response to this notice must
include the agency name (Centers for
Disease Control and Prevention, HHS)
and docket number (CDC–2023–0027,
NIOSH–350) for this action. All relevant
comments, including any personal
information provided, will be posted
without change to https://
www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Rachel Weiss, Program Analyst, 1090
Tusculum Ave., MS C–46, Cincinnati,
OH 45226; Telephone (404) 498–2500
(this is not a toll-free number); Email
NIOSHregs@cdc.gov.
SUPPLEMENTARY INFORMATION: The WTC
Health Program was established by title
I of the James Zadroga 9/11 Health and
Compensation Act of 2010, Public Law
SUMMARY:
Federal Trade Commission.
PO 00000
Frm 00093
Fmt 4703
Sfmt 4703
74493
111–347, as amended by Public Law
114–113, Public Law 116–59, and
Public Law 117–328, adding title XXXIII
to the Public Health Service (PHS) Act
(codified at 42 U.S.C. 300mm–300mm–
62). All references to the Administrator
in this document mean the Director of
the NIOSH within CDC, or his or her
designee.
The WTC Health Program conducts
research among its members receiving
monitoring or treatment in the Program
and in sampled populations outside the
New York City disaster area (NYCDA),
as defined in section 3306(7) of the PHS
Act, in Manhattan as far north as 14th
Street and in Brooklyn.1
In December 2022, the Consolidated
Appropriations Act, 2023 2 amended
section 3341 of the PHS Act to direct the
Administrator, in consultation with the
Secretary of Education, to establish a
new research cohort. The cohort must
be of sufficient size to conduct future
research studies on the health and
educational impacts of ‘‘exposure to
airborne toxins, or any other hazard or
adverse condition, resulting from the
September 11, 2001, terrorist attacks,
including on the population of
individuals who were 21 years of age or
younger at the time of exposure,
including such individuals who are
screening-eligible WTC survivors or
certified-eligible WTC survivors.’’ 3 The
new WTC Health Program youth
research cohort is referred to as ‘‘WTC
Youth.’’ In accordance with section
3341, the cohort of WTC Youth must:
• Be of sufficient size to conduct
future research studies on the health
and educational impacts of 9/11
exposures;
• Include in this group sufficient
representation of individuals who were
21 years of age or younger at the time
of exposure; and
• Include in this group individuals
who are screening-eligible WTC
survivors or certified-eligible WTC
survivors.
The cohort may also include
individuals who were 21 years of age or
younger on September 11, 2001, who
were located outside the NYCDA and in
Manhattan not further north than 14th
Street; or anywhere within the borough
of Brooklyn. Additionally, the cohort
may include age-appropriate control
populations as needed for research
purposes.
1 42
U.S.C. 300mm–51.
Law 117–328 (Dec. 29, 2022).
3 WTC survivors include individuals who lived,
worked, went to school, or attended child or adult
day care in the NYCDA on September 11, 2001, or
in the following days, weeks, or months and those
otherwise meeting the eligibility criteria in 42 CFR
88.7 or 88.8.
2 Public
E:\FR\FM\31OCN1.SGM
31OCN1
Agencies
[Federal Register Volume 88, Number 209 (Tuesday, October 31, 2023)]
[Notices]
[Page 74493]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-23993]
=======================================================================
-----------------------------------------------------------------------
FEDERAL TRADE COMMISSION
Senior Executive Service Performance Review Board
AGENCY: Federal Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given of the appointment of members to the
FTC Performance Review Board.
FOR FURTHER INFORMATION CONTACT: Diane Campbell, Chief Human Capital
Officer, 600 Pennsylvania Avenue NW, Washington, DC 20580, (202) 436-
0152.
SUPPLEMENTARY INFORMATION: Publication of the Performance Review Board
(PRB) membership is required by 5 U.S.C. 4314 (c) (4). The PRB reviews
and evaluates the initial appraisal of a senior executive's performance
by the supervisor, and makes recommendations regarding performance
ratings, performance awards, and pay-for-performance pay adjustments to
the Chair.
The following individuals have been designated to serve on the
Commission's Performance Review Board:
Dianne Campbell, Chief Human Capital Officer
Anisha Dasgupta, General Counsel
Monique Fortenberry, Director, Office of Workplace Inclusivity &
Opportunity
Tara Koslov, Deputy Director, Bureau of Competition
Alison Oldale, Deputy Director, Bureau of Economics
David Robbins, Executive Director, PRB Chair
Monica Vaca, Deputy Director, Bureau of Consumer Protection
By direction of the Commission.
April J. Tabor,
Secretary.
[FR Doc. 2023-23993 Filed 10-30-23; 8:45 am]
BILLING CODE 6750-01-P